skinny.

Latest / IDN Podcast - Daily News

Affordable HIV Prevention Shot Receives U.S. Approval

On Monday, November 2, 2026, the US Food and Drug Administration (FDA) granted tentative approval for a cost-effective generic version of lenacapavir, a revolutionary HIV prevention injection administered twice a year.Produced by Dr. Reddy's Laboratories, an Indian company, this generic medication will be priced at $40 per person annually in 120 low- and middle-income nations. This is a stark contrast to the brand-name alternative, Yeztugo, manufactured by Gilead Sciences, which has a staggering US list price of $28,218 per year.This approval marks a significant triumph for advocates of…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.